Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charlene Biwott"'
Autor:
Ruanne V, Barnabas, Elizabeth R, Brown, Maricianah A, Onono, Elizabeth A, Bukusi, Betty, Njoroge, Rachel L, Winer, Denise A, Galloway, Leeya F, Pinder, Deborah, Donnell, Imelda, Wakhungu, Ouma, Congo, Charlene, Biwott, Syovata, Kimanthi, Linda, Oluoch, Kate B, Heller, Hannah, Leingang, Susan, Morrison, Elena, Rechkina, Stephen, Cherne, Torin T, Schaafsma, R Scott, McClelland, Connie, Celum, Jared M, Baeten, Nelly, Mugo
Publikováno v:
NEJM evidence. 1(5)
Single-dose HPV vaccination, if efficacious, would be tremendously advantageous; simplifying implementation and decreasing costs.We performed a randomized, multi-center, double-blind, controlled trial of single-dose nonavalent (HPV 16/18/31/33/45/52/
Autor:
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah A. Onono, Elizabeth A. Bukusi, Betty Njoroge, Rachel L. Winer, Denise A. Galloway, Leeya F. Pinder, Deborah Donnell, Imelda Wakhungu, Ouma Congo, Charlene Biwott, Syovata Kimanthi, Lynda Oluoch, Kate B. Heller, Hannah Leingang, Susan Morrison, Elena Rechkina, Stephen Cherne, Torin T. Schaafsma, R. Scott McClelland, Connie Celum, Jared M. Baeten, Nelly Mugo
Publikováno v:
NEJM Evidence. 1
Autor:
Ouma Congo, George Otieno, Imeldah Wakhungu, Elizabeth K. Harrington, Syovata Kimanthi, Charlene Biwott, Hannah Leingang, Nelly Mugo, Ruanne V. Barnabas, Elizabeth A. Bukusi, Maricianah Onono
Publikováno v:
Advances in Global Health. 1
Globally, COVID-19 has had a negative impact on health systems and health outcomes, with evidence of differential gender impacts emerging. The COVID-19 timeline of events spanning from closures and restrictions to phased reopenings is well-documented
Autor:
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah A. Onono, Elizabeth A. Bukusi, Betty Njoroge, Rachel L. Winer, Denise A. Galloway, Leeya F. Pinder, Deborah Donnell, Imelda Wakhungu, Ouma Congo, Charlene Biwott, Syovata Kimanthi, Lynda Oluoch, Kate B. Heller, Hannah Leingang, Susan Morrison, Elena Rechkina, Stephen Cherne, Torin T. Schaafsma, R. Scott McClelland, Connie Celum, Jared M. Baeten, Nelly Mugo, for the KEN SHE Study Team
Background: Single-dose HPV vaccination, if efficacious, would be tremendously advantageous; simplifying implementation and decreasing costs.Methods: We performed a randomized, multi-center, double-blind, controlled trial of single-dose nonavalent (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::338944cd34fb28160ff019530752cf0a
https://doi.org/10.21203/rs.3.rs-1090565/v1
https://doi.org/10.21203/rs.3.rs-1090565/v1